Reporting of PPI and the MCID in phase III/IV randomised controlled trials —a systematic review
Patient and public involvement (PPI) in clinical trial design contributes to ensuring the research objectives and outcome measures are relevant to patients. The minimal clinically important difference (MCID) i...
Source: Trials - Category: General Medicine Authors: Joseph Brennan, Michael T. C. Poon, Edward Christopher, Olivia Fulton, Carol Porteous and Paul M. Brennan Tags: Review Source Type: research
More News: Clinical Trials | General Medicine